Symbol not found

:CRXT   00:00AM GMT
0.00
0.00 (0.00%)
Debt Financing / Related, Regulatory, Bankruptcy / Related

Clarus Therapeutics Holdings Announces Plan For Near-Term Sale Of Jatenzo Using Structured Process Through Chapter 11 Of The U.S. Bankruptcy Code

Published: 09/06/2022 02:29 GMT
(CRXT) - Clarus Therapeutics Holdings, Inc. Announces Plan for Near-term Sale of Jatenzo® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code.
Clarus Therapeutics -believes It Has Sufficient Financial Resources to Meet Its Operational and Financial Obligations Through the Chapter 11 Process.